Kite Pharma
Part of Gilead Sciences
Engaged Employer
About Kite Pharma
0 associated companies
Kite, a Gilead Company, is dedicated to achieving one of the most ambitious goals of 21st century medicine: curing cancer. This mission is at the heart of everything we do, from early research to product development.
For the past three decades, members of our team have been at the forefront of cancer immunotherapy. Today, we are a leader in engineered T cell therapy, changing the paradigm of cancer treatment with what is potentially the biggest breakthrough since the introduction of combination chemotherapy more than 60 years ago.
With an unrelenting drive and a singular focus on cell therapy, our team is executing on our strategy to bring life-saving therapies to patients.
In all areas of the company, we are looking for the very best people who share our deep passion to cure cancer. We realize that our ambitious goals can only be achieved if every employee is fully committed to our mission and embraces our entrepreneurial spirit. If this describes you, please contact us.
Parent Company
The company that controls management and sometimes the operations of Kite Pharma.Gilead Sciences3.5★
Gilead Sciences is a global biopharmaceutical company with over 17,000 employees focused on discovering, developing, and delivering innovative medicines for people with serious diseases. For nearly four decades, Gilead has contributed to advances in HIV treatment and prevention and continues to expand research across oncology, liver disease, and inflammatory conditions.
Our work spans the full lifecycle of medicine development, including scientific research, clinical trials, manufacturing, and global commercialization. Teams across research, clinical development, manufacturing, and corporate functions collaborate to translate scientific discovery into therapies that reach patients worldwide.
Gilead operates in more than 35 countries and partners with healthcare providers, research institutions, and global organizations to improve access to medicines and support public health initiatives.
Through Kite Pharma, Gilead also advances cell therapy research, including CAR-T therapies designed to treat certain cancers. Kite’s work represents a key component of Gilead’s oncology strategy and investment in next-generation therapeutic approaches.
290 jobs2.7K reviews14K salaries